Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

Summary

The purpose of this trial is to investigate whether treatment with this new drug will result in lower testosterone levels in men with prostate cancer. At the same time it will be investigated whether the drug induces side effects, and if so, which ones.

Timeline

Start

2008-10

Primary completion

2009-12

Completion

—

Drugs

Indications